A lung adenocarcinoma patient with EGFR mutation in exon 18 and ALKrearrangement who treated with erlotinib and crizotinibMehmet Artaç a,*, Levent Korkmaz a, Mustafa Karaağaç a, Buğra Kaya b, Necdet Poyraz c, Hakan Özön d, Zehra Er a, Lema Tavlı ea Necmettin Erbakan University, Meram Faculty of Medicine, Department of Medical Oncology, Konya, Turkey
b Necmettin Erbakan University, Meram Faculty of Medicine, Department of Nuclear Medicine, Konya, Turkey
c Necmettin Erbakan University, Meram Faculty of Medicine, Department of Radiology, Konya, Turkey
d Istanbul Genetics Laboratory, Istanbul, Turkey
e Necmettin Erbakan University, Meram Faculty of Medicine, Department of Pathology, Konya, TurkeyDOI: 10.1016/j.jons.2018.04.001 Sayfalar: 111 - 113 1645 Viewed.
JOURNAL of
EN